Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
During recessions, some index funds fare better than others. This intro highlights selection criteria and defensive positioning.
25,743 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
A cross-party group of UK lawmakers is probing how banks treat crypto businesses. The inquiry aims to uncover barrier...
When a former chief officer sells stock, investors should look beyond the headline. This guide explains why insider m...
Novocure faces a pivotal year as TTFields therapy expands and reimbursement pathways evolve. This guide breaks down w...
Broadcom’s latest price move came on the back of a price-target cut and AI optimism colliding with caution. This guid...
Kick off your weekend with a thoughtful set of friday reads designed to inform, not echo headlines. This guide blends...
As AI workloads surge, data centers need faster, smarter networking. This piece examines the potential of a predictio...
Markets brace for a year where prices rise while growth falters. This report explains why stagflation: word year 2026...
A notable stake in TowneBank marks a strategic bet by Patriot Financial Partners. This article breaks down what the i...
Trump Mobile says the gold-plated T1 phone will ship this week after nearly year delays, with deposits collected and ...
This article outlines why rental properties can redefine how the average American builds wealth. It offers actionable...
A leaked Meta audio from an April 30 all-hands meeting signals a shift toward leveraging compute and internal output ...